{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:50:02Z","timestamp":1790783402032,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T00:00:00Z","timestamp":1468195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T00:00:00Z","timestamp":1468195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Influenza viruses are among the most common pathogens that threaten the health of humans and animals worldwide. Various anti-viral therapeutic agents are currently used for treatment and prophylaxis of influenza virus, but the targets of these drugs are easily mutated and result in resistance. Therefore, medications that have broad spectrum coverage are urgently needed to combat with the disease. Since nucleoprotein is regarded as a druggable target due to its conserved sequence and important functions during influenza virus life cycle, numerous studies are focused on this protein in attempts to develop broad-spectrum anti-influenza therapeutics. Recently, a novel small molecule compound, nucleozin, was found to induce large aggregates of nucleoprotein, which in turn caused cessation of virus replication. However, the aggregation-inducing mechanism of nucleozin has not been unveiled. Here we report the crystal structure of nucleoprotein-nucleozin complex at 3\u2009\u00c5 resolution, which shows the binding sites of nucleozin at nucleoprotein for the first time. The complex structure reveals how nucleoprotein and nucleozin interact with each other and hence result in nucleoprotein aggregates. The structural information is envisaged to help accelerate the development of anti-influenza therapeutic agents.<\/jats:p>","DOI":"10.1038\/srep29684","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T13:28:37Z","timestamp":1468330117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Structural Characterization of H1N1 Nucleoprotein-Nucleozin Binding Sites"],"prefix":"10.1038","volume":"6","author":[{"given":"Bo","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Nam","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Y.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,11]]},"reference":[{"key":"BFsrep29684_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10156-003-0262-6","volume":"9","author":"H Suzuki","year":"2003","unstructured":"Suzuki, H. et al. Emergence of amantadine-resistant influenza A viruses: epidemiological study. J. Infect. Chemother. 9, 195\u2013200 (2003).","journal-title":"J. Infect. Chemother."},{"key":"BFsrep29684_CR2","unstructured":"Centers for Disease, C. and Prevention. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb. Mortal. Wkly Rep. 58, 433\u20135 (2009)."},{"key":"BFsrep29684_CR3","doi-asserted-by":"crossref","unstructured":"Novel Swine-Origin Influenza, A.V.I.T. et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360, 2605\u201315 (2009).","DOI":"10.1056\/NEJMoa0903810"},{"key":"BFsrep29684_CR4","first-page":"1","volume":"60","author":"AE Fiore","year":"2011","unstructured":"Fiore, A. E. et al. Antiviral agents for the treatment and chemoprophylaxis of influenza \u2014 recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 60, 1\u201324 (2011).","journal-title":"MMWR Recomm. Rep."},{"key":"BFsrep29684_CR5","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","volume":"364","author":"M Kiso","year":"2004","unstructured":"Kiso, M. et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. The Lancet. 364, 759\u2013765 (2004).","journal-title":"The Lancet."},{"key":"BFsrep29684_CR6","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1056\/NEJMoa054512","volume":"353","author":"MD de Jong","year":"2005","unstructured":"de Jong, M. D. et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353, 2667\u201372 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep29684_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2334-11-134","volume":"11","author":"K Thorlund","year":"2011","unstructured":"Thorlund, K. et al. Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect. Dis. 11, 134 (2011).","journal-title":"BMC Infect. Dis."},{"key":"BFsrep29684_CR8","first-page":"1647","volume":"2","author":"P Palese","year":"2007","unstructured":"Palese, P. & Shaw, M. L. Orthomyxoviridae: The Viruses and Their Replication. in Fields Virology 5th edn, Vol. 2 (eds Knipe, D. M. & Howley, P. M. ) 1647\u20131689 (Wolters Kluwer, 2007).","journal-title":"Fields Virology 5th edn"},{"key":"BFsrep29684_CR9","doi-asserted-by":"publisher","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","volume":"26","author":"NM Bouvier","year":"2008","unstructured":"Bouvier, N. M. & Palese, P. The biology of influenza viruses. Vaccine. 26 Suppl 4, D49\u201353 (2008).","journal-title":"Vaccine."},{"key":"BFsrep29684_CR10","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nature04239","volume":"437","author":"E Ghedin","year":"2005","unstructured":"Ghedin, E. et al. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature. 437, 1162\u20136 (2005).","journal-title":"Nature."},{"key":"BFsrep29684_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1099\/0022-1317-83-4-723","volume":"83","author":"A Portela","year":"2002","unstructured":"Portela, A. & Digard, P. The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J. Gen. Virol. 83, 723\u2013734 (2002).","journal-title":"J. Gen. Virol."},{"key":"BFsrep29684_CR12","first-page":"40","volume":"454\u2013455","author":"A Kukol","year":"2013","unstructured":"Kukol, A. & Hughes, D. J. Large-scale analysis of influenza A virus nucleoprotein sequence conservation reveals potential drug-target sites. Virology. 454\u2013455, 40\u201347 (2013).","journal-title":"Virology."},{"key":"BFsrep29684_CR13","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/nbt.1638","volume":"28","author":"RY Kao","year":"2010","unstructured":"Kao, R. Y. et al. Identification of influenza A nucleoprotein as an antiviral target. Nature Biotechnology. 28, 600\u2013605 (2010).","journal-title":"Nature Biotechnology."},{"key":"BFsrep29684_CR14","doi-asserted-by":"publisher","first-page":"15366","DOI":"10.1073\/pnas.1107906108","volume":"108","author":"SW Gerritz","year":"2011","unstructured":"Gerritz, S. W. et al. Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers. Proc. Natl. Acad. Sci. USA 108, 15366\u201371 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep29684_CR15","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/nature05379","volume":"444","author":"Q Ye","year":"2006","unstructured":"Ye, Q., Krug, R. M. & Tao, Y. J. The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature. 444, 1078\u201382 (2006).","journal-title":"Nature."},{"key":"BFsrep29684_CR16","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1096\/fj.08-112110","volume":"22","author":"AK Ng","year":"2008","unstructured":"Ng, A. K. et al. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design. FASEB J. 22, 3638\u201347 (2008).","journal-title":"FASEB J."},{"key":"BFsrep29684_CR17","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"BFsrep29684_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods In Enzymology Vol. 276, Macromolecular Crystallography, part A, 307\u2013326 (1997).","journal-title":"Methods In Enzymology"},{"key":"BFsrep29684_CR19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. App. Crystal. 40, 658\u2013674 (2007).","journal-title":"J. App. Crystal."},{"key":"BFsrep29684_CR20","doi-asserted-by":"crossref","unstructured":"Collaborative Computational Project, N. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr. 50, 760\u2013763 (1994).","DOI":"10.1107\/S0907444994003112"},{"key":"BFsrep29684_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1107\/S090744499801405X","volume":"55","author":"GN Murshudov","year":"1999","unstructured":"Murshudov, G. N. et al. Efficient anisotropic refinement of macromolecular structures using FFT. Acta Crystallogr D Biol Crystallogr. 55, 247\u2013255 (1999).","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"BFsrep29684_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P. et al. Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"BFsrep29684_CR23","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1107\/S0907444904011679","volume":"60","author":"AW Schu\u00c8ttelkopf","year":"2004","unstructured":"Schu\u00c8ttelkopf, A. W. & Van Aalten, D. M. PRODRG: a tool for high-throughput crystallography of protein\u2013ligand complexes. Acta Crystallogr D Biol Crystallogr. 60, 1355\u20131363 (2004).","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"BFsrep29684_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski, R. A. et al. Procheck - a Program to Check the Stereochemical Quality of Protein Structures. J. App. Crystal. 26, 283\u2013291 (1993).","journal-title":"J. App. Crystal."},{"key":"BFsrep29684_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0022-2836(03)00670-3","volume":"331","author":"JJ Gray","year":"2003","unstructured":"Gray, J. J. et al. Protein\u2013protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations. J. Mol. Biol. 331, 281\u2013299 (2003).","journal-title":"J. Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep29684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep29684","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep29684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T06:12:29Z","timestamp":1672899149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep29684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,11]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,7,29]]}},"alternative-id":["BFsrep29684"],"URL":"https:\/\/doi.org\/10.1038\/srep29684","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,11]]},"assertion":[{"value":"25 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29684"}}